DA-1241

DRUG3 trials

Sponsors

Dong-A ST Co., Ltd., NeuroBo Pharmaceuticals Inc.

Conditions

Diabetes Mellitus, Type 2NON-ALCOHOLIC STEATOHEPATITIS

Phase 1

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

CompletedNCT03061981

Dong-A ST Co., Ltd.Diabetes Mellitus, Type 2

Start: 2017-03-29End: 2017-10-11Updated: 2017-11-20

A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

CompletedNCT03646721

Dong-A ST Co., Ltd.Diabetes Mellitus, Type 2

Start: 2018-08-29End: 2020-05-07Updated: 2021-02-11

Phase 2

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

CompletedNCT06054815

NeuroBo Pharmaceuticals Inc.NON-ALCOHOLIC STEATOHEPATITIS

Start: 2023-09-14End: 2024-10-30Updated: 2024-11-14